Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis.
Ontology highlight
ABSTRACT: Amyotrophic lateral sclerosis (ALS) is a complex, fatal neurodegenerative disease. Disease pathophysiology is incompletely understood but evidence suggests gut dysbiosis occurs in ALS, linked to impaired gastrointestinal integrity, immune system dysregulation and altered metabolism. Gut microbiome and plasma metabolome have been separately investigated in ALS, but little is known about gut microbe-plasma metabolite correlations, which could identify robust disease biomarkers and potentially shed mechanistic insight. Here, gut microbiome changes were longitudinally profiled in ALS and correlated to plasma metabolome. Gut microbial structure at the phylum level differed in ALS versus control participants, with differential abundance of several distinct genera. Unsupervised clustering of micr
SUBMITTER: Guo K
PROVIDER: S-EPMC10834248 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA